Yintong Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yintong Huang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Beisi Lin
Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Key Laboratory of Diabetology of Guangdong Province, Guangzhou 510630, China
1 shared publication - Daizhi Yang
Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Key Laboratory of Diabetology of Guangdong Province, Guangzhou 510630, China
1 shared publication - Longyi Zeng
Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
1 shared publication - Ruofan Wang
Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Key Laboratory of Diabetology of Guangdong Province, Guangzhou 510630, China
1 shared publication - Shuo Lin
Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Key Laboratory of Diabetology of Guangdong Province, Guangzhou 510630, China
1 shared publication - Wei Jiang
Department of General Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510530, China
1 shared publication
Latest Publications
- Open Access
- 25 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8297
Effects of Intensive Insulin Therapy Within One Week on Glycemic Control and β-Cell Function in Patients with T2DM
Objective: To evaluate the impact of intensive insulin therapy (IIT) within 1 week on glycemic control and β-cell function indices in patients with type 2 diabetes mellitus (T2DM). Methods: This retrospective study included 726 patients with T2DM who underwent continuous subcutaneous insulin infusion within 1 week. Patients were divided into three groups based on disease duration: short (≤1 year), medium (>1 and p < 0.01 for both). HOMA-β, 30 min insulinogenic index, 30 min disposition index, and insulin secretion sensitivity index-2 markedly improved from baseline [37.69 (41.03) VS. 32.40 (46.06), 3.16 (3.97) VS. 2.12 (3.51), 336.85 (397.05) VS. 188.93 (263.45), and 185.92 (122.89) VS. 120.81 (90.12), respectively] (p < 0.01 for all). Insulin sensitivity, measured by HOMA-IR and Matsuda index, significantly improved (p < 0.01 for both). Significantly greater improvements in glycemic control and β-cell function measures were observed in patients with a shorter diabetes duration. Age, duration of diabetes, BMI, HbA1c, duration of IIT, and time in range were significantly associated with improvements in β-cell function indices. Conclusions: IIT within 1 week was associated with improved glycemic control and β-cell function indices in T2DM patients, with the most pronounced benefits observed in those with a shorter disease duration.
- 25 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8297
Open AccessEffects of Intensive Insulin Therapy Within One Week on Glycemic Control and β-Cell Function in Patients with T2DM
Objective: To evaluate the impact of intensive insulin therapy (IIT) within 1 week on glycemic control and β-cell function indices in patients with type 2 diabetes mellitus (T2DM). Methods: This retrospective study included 726 patients with T2DM who underwent continuous subcutaneous insulin infusion within 1 week. Patients were divided into three groups based on disease duration: short (≤1 year), medium (>1 and p < 0.01 for both). HOMA-β, 30 min insulinogenic index, 30 min disposition index, and insulin secretion sensitivity index-2 markedly improved from baseline [37.69 (41.03) VS. 32.40 (46.06), 3.16 (3.97) VS. 2.12 (3.51), 336.85 (397.05) VS. 188.93 (263.45), and 185.92 (122.89) VS. 120.81 (90.12), respectively] (p < 0.01 for all). Insulin sensitivity, measured by HOMA-IR and Matsuda index, significantly improved (p < 0.01 for both). Significantly greater improvements in glycemic control and β-cell function measures were observed in patients with a shorter diabetes duration. Age, duration of diabetes, BMI, HbA1c, duration of IIT, and time in range were significantly associated with improvements in β-cell function indices. Conclusions: IIT within 1 week was associated with improved glycemic control and β-cell function indices in T2DM patients, with the most pronounced benefits observed in those with a shorter disease duration.